Skip to content

Management of Diabetes Mellitus Type 2 through Ayurveda

CLINICAL EVALUATION OF THE KATANKATERYADI KWATH IN THE MANAGEMENT OF MADHUMEHA (DIABETES MELLITUS TYPE 2) - DM

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033317
Enrollment
50
Registered
2021-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Katankateryadi Kwath: Katankateryadi Kwath in the dose of 30-50 ml twice a day for 2 Months Control Intervention1: NIL: NIL

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed & confirmed patients of Diabetes Mellitus on the basis of Modern texts. Patients of 30 to 70 years age having sign and symptoms of diabetes mellitus will be selected for the study. Patient having their Blood sugar level > 125mg/dl to 200mg/dl to Patients with presence symptoms of Prabhutamutrata, Aavilmutrata, Pipasadhikya, Kshudadhikya, Kara pada taladaha, Kara pada tala supti,Alasya,Pindiko-udveshatan,Mutramadhurya, Daurbalyta, Pandurvarnamutrataetc.

Exclusion criteria

Exclusion criteria: Patients who were addict drugs and drinking Age below 30 and above 70 years Insulin dependent diabetic patients DM with complications. The patients suffering from heart diseases, hemiplegia and other chronic disorders will be excluded from the study. Uncontrolled DM ( >600 mg/dl) Pregnant woman

Design outcomes

Primary

MeasureTime frame
Subjective Parameter- Prabhuta Mutrata, Pipasadhikya, Kshudhadhikya, Avila Mutrata, Kara Pada Tala Daha, Kara Pada Tala Supti, Pindiko udveshatan, Mutramadhurya, Daurbalyta, Pandurvarna Mutrata. Objective Parameters- Blood Sugar Fasting, Blood Sugar PP, Blood Sugar Random, CBC, Urine Complete, RFT, LFT, HbA1cTimepoint: 2 months

Secondary

MeasureTime frame
On the basis of improvement in subjective and objective criteriaTimepoint: 2 months

Countries

India

Contacts

Public ContactDr Manisha Gurjar

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

bkmudgal9@gmail.com9460318138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026